DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
IRL790
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IRL790
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GRAPIPRANT
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Osteoarthritis
Prostanoid EP4 receptor antagonist
GRAPIPRANT
×
Maximum Phase:
2
First Approval:
None
UNII:
J9F5ZPH7NB
Molecule Type:
Small molecule
Molecular Formula:
C26H29N5O3S
Molecular Weight:
491.62
AlogP:
4.14
PSA:
105.98
HBD:
2.0
HBA:
#RotB:
7.0
Source:
EVENAMIDE
2
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Sodium channel alpha subunit blocker
EVENAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
ON5S6N53JS
Molecule Type:
Small molecule
Molecular Formula:
C16H26N2O2
Molecular Weight:
278.4
AlogP:
2.09
PSA:
41.57
HBD:
1.0
HBA:
#RotB:
9.0
Source:
GS-0938
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GS-0938
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLOROPHENYLPIPERAZINE
2
Small molecule
Investigational
Unknown
Unknown
Alcoholism; Cocaine-Related Disorders
Unknown
CHLOROPHENYLPIPERAZINE
×
Maximum Phase:
2
First Approval:
None
UNII:
REY0CNO998
Molecule Type:
Small molecule
Molecular Formula:
C10H13ClN2
Molecular Weight:
196.68
AlogP:
1.75
PSA:
15.27
HBD:
1.0
HBA:
#RotB:
1.0
Source:
ARTEROLANE
2
Small molecule
Investigational
Unknown
Unknown
Malaria, Falciparum
Unknown
ARTEROLANE
×
Maximum Phase:
2
First Approval:
None
UNII:
3N1TN351VB
Molecule Type:
Small molecule
Molecular Formula:
C29H44N2O7S
Molecular Weight:
564.75
AlogP:
3.25
PSA:
82.81
HBD:
2.0
HBA:
#RotB:
4.0
Source:
REGRELOR
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
REGRELOR
×
Maximum Phase:
2
First Approval:
None
UNII:
Q6C8TY6SW1
Molecule Type:
Small molecule
Molecular Formula:
C22H25N6O8P
Molecular Weight:
532.45
AlogP:
1.8
PSA:
179.18
HBD:
4.0
HBA:
#RotB:
8.0
Source:
E-7090
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Liver Diseases; Cholangiocarcinoma; Neoplasms
Fibroblast growth factor receptor 1 inhibitor
E-7090
×
Maximum Phase:
2
First Approval:
None
UNII:
TN7CUD1NGA
Molecule Type:
Small molecule
Molecular Formula:
C32H37N5O6
Molecular Weight:
587.68
AlogP:
4.47
PSA:
127.18
HBD:
3.0
HBA:
#RotB:
11.0
Source:
TEMPOL
2
Small molecule
Investigational
Unknown
Unknown
Anus Neoplasms; Cardiovascular Diseases; Alopecia; Glioblastoma; Prostatic Neoplasms, Castration-Resistant; Severe Acute Respiratory Syndrome
Unknown
TEMPOL
×
Maximum Phase:
2
First Approval:
None
UNII:
U78ZX2F65X
Molecule Type:
Small molecule
Molecular Formula:
C9H18NO2
Molecular Weight:
172.25
AlogP:
1.35
PSA:
43.37
HBD:
1.0
HBA:
#RotB:
0.0
Source:
GUSACITINIB
2
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Dermatitis; Dermatitis, Atopic
Janus Kinase (JAK) inhibitor
GUSACITINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
4801QYW816
Molecule Type:
Small molecule
Molecular Formula:
C24H28N8O2
Molecular Weight:
460.54
AlogP:
2.55
PSA:
134.06
HBD:
3.0
HBA:
#RotB:
5.0
Source:
LURTOTECAN
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Fallopian Tube Neoplasms; Head and Neck Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Small Cell Lung Carcinoma
Unknown
LURTOTECAN
×
Maximum Phase:
2
First Approval:
None
UNII:
4J1L80T08I
Molecule Type:
Small molecule
Molecular Formula:
C28H30N4O6
Molecular Weight:
518.57
AlogP:
1.6
PSA:
106.36
HBD:
1.0
HBA:
#RotB:
3.0
Source:
AKN-028
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Tyrosine-protein kinase receptor FLT3 inhibitor
AKN-028
×
Maximum Phase:
2
First Approval:
None
UNII:
Y66IS3CS0R
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AXOMADOL
2
Small molecule
Investigational
Unknown
Unknown
Chronic Pain; Pain; Low Back Pain
Delta opioid receptor agonist
AXOMADOL
×
Maximum Phase:
2
First Approval:
None
UNII:
9J92U4CVS0
Molecule Type:
Small molecule
Molecular Formula:
C16H25NO3
Molecular Weight:
279.38
AlogP:
1.61
PSA:
52.93
HBD:
2.0
HBA:
#RotB:
4.0
Source:
ATRELEUTON
2
Small molecule
Investigational
Unknown
Unknown
Acute Coronary Syndrome; Atherosclerosis; Coronary Disease
Arachidonate 5-lipoxygenase inhibitor
ATRELEUTON
×
Maximum Phase:
2
First Approval:
None
UNII:
U301T88E1M
Molecule Type:
Small molecule
Molecular Formula:
C16H15FN2O2S
Molecular Weight:
318.37
AlogP:
2.99
PSA:
66.56
HBD:
2.0
HBA:
#RotB:
3.0
Source:
AZTREONAM LYSINE
2
Small molecule
Investigational
Unknown
Unknown
Bronchiectasis
Unknown
AZTREONAM LYSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
XNM7LT65NP
Molecule Type:
Small molecule
Molecular Formula:
C19H31N7O10S2
Molecular Weight:
581.63
AlogP:
-1.17
PSA:
201.58
HBD:
4.0
HBA:
#RotB:
7.0
Source:
ESUBERAPROST
3
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Prostanoid IP receptor agonist
ESUBERAPROST
×
Maximum Phase:
3
First Approval:
None
UNII:
1JSN1I7582
Molecule Type:
Small molecule
Molecular Formula:
C24H30O5
Molecular Weight:
398.5
AlogP:
3.29
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
8.0
Source:
DUTOGLIPTIN
3
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Dipeptidyl peptidase IV inhibitor
DUTOGLIPTIN
×
Maximum Phase:
3
First Approval:
None
UNII:
38EAO245ZX
Molecule Type:
Small molecule
Molecular Formula:
C10H20BN3O3
Molecular Weight:
241.1
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CITICOLINE SODIUM
3
Small molecule
Investigational
Unknown
Unknown
Brain Injuries; Schizophrenia; Substance-Related Disorders; Amphetamine-Related Disorders
Unknown
CITICOLINE SODIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
7XQ5AKD9YD
Molecule Type:
Small molecule
Molecular Formula:
C14H25N4NaO11P2
Molecular Weight:
510.31
AlogP:
-2.23
PSA:
215.72
HBD:
4.0
HBA:
#RotB:
10.0
Source:
YH25448
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
YH25448
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TARANABANT
3
Small molecule
Investigational
Unknown
Unknown
Tobacco Use Disorder; Urinary Incontinence; Diabetes Mellitus, Type 2; Obesity
Cannabinoid CB1 receptor inverse agonist
TARANABANT
×
Maximum Phase:
3
First Approval:
None
UNII:
X9U622S114
Molecule Type:
Small molecule
Molecular Formula:
C27H25ClF3N3O2
Molecular Weight:
515.96
AlogP:
6.31
PSA:
75.01
HBD:
1.0
HBA:
#RotB:
8.0
Source:
VALNOCTAMIDE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VALNOCTAMIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
3O25NRX9YG
Molecule Type:
Small molecule
Molecular Formula:
C8H17NO
Molecular Weight:
143.23
AlogP:
1.54
PSA:
43.09
HBD:
1.0
HBA:
#RotB:
4.0
Source:
NAPROXCINOD
3
Small molecule
Investigational
Unknown
Unknown
Liver Diseases; Renal Insufficiency; Osteoarthritis; Osteoarthritis, Hip; Rheumatic Diseases
Cyclooxygenase inhibitor
NAPROXCINOD
×
Maximum Phase:
3
First Approval:
None
UNII:
V24GR4LI3I
Molecule Type:
Small molecule
Molecular Formula:
C18H21NO6
Molecular Weight:
347.37
AlogP:
3.48
PSA:
87.9
HBD:
0.0
HBA:
#RotB:
9.0
Source:
SAMARIUM
3
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms
Unknown
SAMARIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
42OD65L39F
Molecule Type:
Small molecule
Molecular Formula:
Sm
Molecular Weight:
150.36
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ZEAXANTHIN
3
Small molecule
Investigational
Unknown
Unknown
Glaucoma
Unknown
ZEAXANTHIN
×
Maximum Phase:
3
First Approval:
None
UNII:
CV0IB81ORO
Molecule Type:
Small molecule
Molecular Formula:
C40H56O2
Molecular Weight:
568.89
AlogP:
10.55
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
10.0
Source:
TRIPHOSPHATE
3
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TRIPHOSPHATE
×
Maximum Phase:
3
First Approval:
None
UNII:
NU43IAG5BC
Molecule Type:
Small molecule
Molecular Formula:
H5O10P3
Molecular Weight:
257.95
AlogP:
-0.69
PSA:
170.82
HBD:
5.0
HBA:
#RotB:
4.0
Source:
PRIDOPIDINE
3
Small molecule
Investigational
Unknown
Unknown
Amyotrophic Lateral Sclerosis; Parkinson Disease; Huntington Disease
Dopamine D2 receptor modulator
PRIDOPIDINE
×
Maximum Phase:
3
First Approval:
None
UNII:
HD4TW8S2VK
Molecule Type:
Small molecule
Molecular Formula:
C15H23NO2S
Molecular Weight:
281.42
AlogP:
2.68
PSA:
37.38
HBD:
0.0
HBA:
#RotB:
4.0
Source:
ROXADUSTAT
3
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases; ST Elevation Myocardial Infarction; Anemia; Myelodysplastic Syndromes; Renal Insufficiency, Chronic
Hypoxia-inducible factor prolyl hydroxylase inhibitor
ROXADUSTAT
×
Maximum Phase:
3
First Approval:
None
UNII:
X3O30D9YMX
Molecule Type:
Small molecule
Molecular Formula:
C19H16N2O5
Molecular Weight:
352.35
AlogP:
2.86
PSA:
108.75
HBD:
3.0
HBA:
#RotB:
5.0
Source:
ICARIIN
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ICARIIN
×
Maximum Phase:
3
First Approval:
None
UNII:
VNM47R2QSQ
Molecule Type:
Small molecule
Molecular Formula:
C33H40O15
Molecular Weight:
676.67
AlogP:
0.07
PSA:
238.2
HBD:
8.0
HBA:
#RotB:
9.0
Source:
VANIPREVIR
3
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Infections; Hepatitis C, Chronic
Hepatitis C virus serine protease, NS3/NS4A inhibitor
VANIPREVIR
×
Maximum Phase:
3
First Approval:
None
UNII:
CV3X74AO1H
Molecule Type:
Small molecule
Molecular Formula:
C38H53N5O9S
Molecular Weight:
755.93
AlogP:
3.67
PSA:
180.52
HBD:
3.0
HBA:
#RotB:
6.0
Source:
PYRIMIDINE
3
Small molecule
Investigational
Unknown
Unknown
Rectal Neoplasms; Colorectal Neoplasms; Stomach Neoplasms
Unknown
PYRIMIDINE
×
Maximum Phase:
3
First Approval:
None
UNII:
K8CXK5Q32L
Molecule Type:
Small molecule
Molecular Formula:
C4H4N2
Molecular Weight:
80.09
AlogP:
0.48
PSA:
25.78
HBD:
0.0
HBA:
#RotB:
0.0
Source:
QAW039
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
QAW039
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
4-HYDROXYTAMOXIFEN
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
4-HYDROXYTAMOXIFEN
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
WATER O 15
3
Small molecule
Investigational
Unknown
Unknown
Stress Disorders, Post-Traumatic
Unknown
WATER O 15
×
Maximum Phase:
3
First Approval:
None
UNII:
63M8RYN44N
Molecule Type:
Small molecule
Molecular Formula:
H2O
Molecular Weight:
17.02
AlogP:
-0.82
PSA:
31.5
HBD:
0.0
HBA:
#RotB:
0.0
Source:
CB-5945
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CB-5945
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIETHANOLAMINE
3
Small molecule
Investigational
Unknown
Unknown
Ischemia; Hypertension, Pulmonary
Unknown
DIETHANOLAMINE
×
Maximum Phase:
3
First Approval:
None
UNII:
AZE05TDV2V
Molecule Type:
Small molecule
Molecular Formula:
C4H11NO2
Molecular Weight:
105.14
AlogP:
-1.44
PSA:
52.49
HBD:
3.0
HBA:
#RotB:
4.0
Source:
1
2
…
135
136
137
138
139
140
141
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA